Fig. 1

Cell viability (MTT) assay. a Trophoblasts treated with increasing concentrations of PPF (μg/mL). b Trophoblasts infected with VSV-GFP (MOI of 1.0) and treated with increasing concentrations of PPF (μg/mL). c HeLa cells treated with increasing concentrations of PPF (μg/mL). d HeLa cells infected with VSV-GFP (MOI of 1.0) and treated with increasing concentrations of PPF (μg/mL). e Jurkat cells treated with increasing concentrations of PPF (μg/mL). f Jurkat cells infected with VSV-GFP (MOI of 1.0) and treated with increasing concentrations of PPF (μg/mL)